Pulmonary Alveolar Proteinosis

21 Nov 2026 14:00 14:25
Marissa O'Callaghan Speaker Ireland
Pulmonary alveolar proteinosis (PAP) is a rare but treatable cause of respiratory impairment that presents important diagnostic and therapeutic challenges. Using a case-based approach, this presentation will explore when to suspect PAP, how to confirm the diagnosis and distinguish its underlying causes, and when to consider treatment. It will highlight the roles of bronchoalveolar lavage and GM-CSF autoantibody testing, alongside practical approaches to assessing disease severity and progression. Established and emerging treatments, including whole-lung lavage and inhaled GM-CSF, will be discussed. Attendees will gain a practical framework for recognising PAP, initiating appropriate investigations and identifying patients who would benefit from specialist referral.